Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles
Small Methods · 2023
DOI: 10.1002/smtd.202201695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2023. Verfasst von Morag Rose Hunter und 13 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK. Hauptthemen laut MEDLINE: Endocytosis, Nanoparticles. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, AstraZeneca.
Abstract (Originalsprache)
Poor understanding of intracellular delivery and targeting hinders development of nucleic acid‐based therapeutics transported by nanoparticles. Utilizing a siRNA‐targeting and small molecule profiling approach with advanced imaging and machine learning biological insights is generated into the mechanism of lipid nanoparticle (MC3‐LNP) delivery of mRNA. This workflow is termed Advanced Cellular and Endocytic profiling for Intracellular Delivery (ACE‐ID). A cell‐based imaging assay and perturbation of 178 targets relevant to intracellular trafficking is used to identify corresponding effects on functional mRNA delivery. Targets improving delivery are analyzed by extracting data‐rich phenotypic fingerprints from images using advanced image analysis algorithms. Machine learning is used to determine key features correlating with enhanced delivery, identifying fluid‐phase endocytosis as a productive cellular entry route. With this new knowledge, MC3‐LNP is re‐engineered to target macropinocytosis, and this significantly improves mRNA delivery in vitro and in vivo. The ACE‐ID approach can be broadly applicable for optimizing nanomedicine‐based intracellular delivery systems and has the potential to accelerate the development of delivery systems for nucleic acid‐based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
- Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.
- Molecular AI, Discovery Sciences, R&D, Astrazeneca, Gothenburg, 431 50, Sweden.
- Functional Genomics, Discovery Sciences, R&D, AstraZeneca, Cambridge, CB4 0WG, UK.
- Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, 431 50, Sweden.
- Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, CF10 3NB, UK.
ORCID-Profile: Morag Rose Hunter, Lili Cui, Benjamin Thomas Porebski, Silvia Sonzini, Ola Engkvist, Samantha Peel, Alan Sabirsh, Arwyn Tomos Jones
Förderung
- Medical Research Council
- AstraZeneca
Zitieren
APA
Hunter, M. R., Cui, L., Porebski, B. T., Pereira, S., Sonzini, S., Odunze, U., Iyer, P., Engkvist, O., Lloyd, R. L., Peel, S., Sabirsh, A., Ross-Thriepland, D., Jones, A. T., & Desai, A. S. (2023). Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles. Small Methods. https://doi.org/10.1002/smtd.202201695
Vancouver
Hunter MR, Cui L, Porebski BT, Pereira S, Sonzini S, Odunze U, et al. Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles. Small Methods. 2023. doi:10.1002/smtd.202201695
BibTeX
@article{Hunter2023,
author = {Hunter, Morag Rose and Cui, Lili and Porebski, Benjamin Thomas and Pereira, Sara and Sonzini, Silvia and Odunze, Uchechukwu and Iyer, Preeti and Engkvist, Ola and Lloyd, Rebecca Louise and Peel, Samantha and Sabirsh, Alan and Ross-Thriepland, Douglas and Jones, Arwyn Tomos and Desai, Arpan Shailesh},
title = {Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles},
journal = {Small Methods},
year = {2023},
doi = {10.1002/smtd.202201695}
}
EUVIMED